MeiraGTx Holdings (MGTX) Non-Current Deffered Revenue (2017 - 2025)

MeiraGTx Holdings (MGTX) posted Non-Current Deffered Revenue of $65.1 million for Q4 2025, up 1.42% on a QoQ basis from $64.2 million in Q3 2025, and up 13.1% year-over-year from $57.6 million in Q4 2024.

MeiraGTx Holdings (MGTX) Non-Current Deffered Revenue (2017 - 2025) Analysis & Trends

MeiraGTx Holdings' Non-Current Deffered Revenue history runs 9 years deep, the most recent figure standing at $65.1 million for Q4 2025.

  • Quarterly Non-Current Deffered Revenue rose 13.1% year-over-year to $65.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $65.1 million (up 13.1% YoY) and the FY2025 annual result came in at $65.1 million, up 13.1% from the prior year.
  • Non-Current Deffered Revenue was $65.1 million for Q4 2025 at MeiraGTx Holdings, up from $64.2 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $65.1 million in Q4 2025 and bottomed at $15.5 million in Q3 2022.
  • A 5-year average of $42.2 million and a median of $41.2 million in 2021 frame the typical range for Non-Current Deffered Revenue.
  • Annual changes were most pronounced in 2022 — Non-Current Deffered Revenue slumped 52.33% — and 2024, when it surged 153.99%.
  • MeiraGTx Holdings' Non-Current Deffered Revenue stood at $43.0 million in 2021, then sank by 36.26% to $27.4 million in 2022, then advanced by 23.99% to $34.0 million in 2023, then jumped by 69.26% to $57.6 million in 2024, then grew by 13.1% to $65.1 million in 2025.
  • Business Quant data shows MGTX's Non-Current Deffered Revenue at $65.1 million in Q4 2025, $64.2 million in Q3 2025, and $63.0 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 225.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 MeiraGTx Holdings 973.21 Mn 907.27 Mn - 65.12 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 65.12 Mn
Sep 30, 2025 64.21 Mn
Jun 30, 2025 63.04 Mn
Mar 31, 2025 59.62 Mn
Dec 31, 2024 57.58 Mn
Sep 30, 2024 58.90 Mn
Jun 30, 2024 53.76 Mn
Mar 31, 2024 53.33 Mn
Dec 31, 2023 34.02 Mn
Sep 30, 2023 23.19 Mn
Jun 30, 2023 25.36 Mn
Mar 31, 2023 26.43 Mn
Dec 31, 2022 27.44 Mn
Sep 30, 2022 15.49 Mn
Jun 30, 2022 21.34 Mn
Mar 31, 2022 37.28 Mn
Dec 31, 2021 43.05 Mn
Sep 30, 2021 32.49 Mn
Jun 30, 2021 39.33 Mn
Mar 31, 2021 43.30 Mn